USE OF A CB1 CANNABINOID RECEPTOR ANTAGONIST FOR PRODUCING MEDICAMENTS WHICH ARE USEFUL FOR TREATING SEXUAL BEHAVIOUR PROBLEMS AND/OR FOR IMPROVING SEXUAL PERFORMANCES

摘要

The invention relates to the use of a CB1 cannabinoid receptor antagonist, especially rimonabant and N-piperidino-5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethylpyrazole-3-carboxamide and the pharmaceutically acceptable salts and solvates thereof, for producing medicaments which are useful for treating sexual behaviour problems and/or for improving sexual performances.